PDS Biotechnology
PDSB
PDSB
78 hedge funds and large institutions have $39.7M invested in PDS Biotechnology in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 80 → 78 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
Holders
78
Holding in Top 10
–
Calls
$1.62M
Puts
$1.58M
Top Buyers
| 1 | +$1.51M | |
| 2 | +$356K | |
| 3 | +$242K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$228K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$131K |
Top Sellers
| 1 | -$808K | |
| 2 | -$593K | |
| 3 | -$538K | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$380K |
| 5 |
LPL Financial
San Diego,
California
|
-$357K |